Barclays Upgrades BRF to Overweight, Raises Price Target to $4
$BRFS
Meat/Poultry/Fish
Consumer Staples
Barclays analyst Benjamin Theurer upgrades BRF (NYSE:BRFS) from Equal-Weight to Overweight and raises the price target from $2.5 to $4.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/15/2024 | Neutral → Overweight | JP Morgan | |
| 12/6/2023 | Overweight → Neutral | JP Morgan | |
| 8/4/2023 | Neutral → Overweight | JP Morgan | |
| 6/1/2023 | Underperform → Neutral | BofA Securities | |
| 5/31/2023 | Neutral → Sell | Goldman | |
| 4/13/2023 | Neutral → Underperform | BofA Securities | |
| 11/28/2022 | $2.50 | Underweight → Equal Weight | Barclays |
| 11/16/2022 | Sell → Neutral | Goldman |
BELO HORIZONTE, Brazil, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Inter&Co (("Inter", NASDAQ:INTR), the premier Super App providing financial and digital commerce services to more than 25 million customers in Brazil and the US, announced today changes to the composition of its Board of Directors. These changes include the appointment of three new Directors and the retirement of two existing Directors, resulting in the expansion of the Inter&Co Board of Directors to ten members. Effective immediately, Antonio Kandir, Todd Crawford Chapman and Lorival Nogueira Luz Júnior have been appointed and join the Board under the Interim format until Inter's 2023 Annual General Meeting, to be held in April, w
USA News Group Commentary Issued on behalf of BioVaxys Technology Corp. VANCOUVER, BC, Aug. 19, 2024 /PRNewswire/ -- USA News Group – How we take care of the planet, and the food we eat is rapidly shifting. Back in May, the World Economic Forum addressed how countries are redefining their bioeconomy for the future, with each aiming for sustainable solutions. NGOs around the world are calling for urgent action to accelerate nature-based solutions to tackle global challenges, while the World Bank is encouraging sustainable agriculture, not an end to farming. Behind the scenes, several biotech firms are working on solutions that can help foster these types of goals, including BioVaxys Technolog
SÃO PAULO, April 19, 2024 /PRNewswire/ -- BRF S.A. ("BRF" or "Company") ((B3: BRFS3, NYSE:BRFS) announces to its shareholders and the general market that it filed on this date, its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC") and with the Brazilian Securities Commission ("CVM"), in English version. The version of the Form 20-F translated into Portuguese will be filed shortly with the CVM and made available on the Company's website. In compliance with the New York Stock Exchange rules, the Form 20-F is available on our website https://ri.brf-global.com/en/. In addition, all shareholders of BRF may request, free of ch
SÃO PAULO, April 28, 2023 /PRNewswire/ -- BRF S.A. ("BRF" or "Company") ((B3: BRFS3, NYSE:BRFS) announces to its shareholders and the general market that it filed, on this date, its Annual Report on Form 20-F for the year ended December 31, 2022 with the U.S. Securities and Exchange Commission ("SEC") and with the Brazilian Securities Commission ("CVM"), in English version. The version of the Form 20-F translated into Portuguese will be filed shortly with the CVM and made available on the Company's website. In compliance with the New York Stock Exchange rules, the Form 20-F is available on our website https://ri.brf-global.com/en/. In addition, all shareholders of BRF may request, free of ch
JP Morgan upgraded BRF SA from Neutral to Overweight
JP Morgan downgraded BRF SA from Overweight to Neutral
JP Morgan upgraded BRF SA from Neutral to Overweight
SC 13D/A - BRF S.A. (0001122491) (Subject)
SC 13D/A - BRF S.A. (0001122491) (Subject)
SC 13D/A - BRF S.A. (0001122491) (Subject)
6-K - BRF S.A. (0001122491) (Filer)
6-K - BRF S.A. (0001122491) (Filer)
6-K - BRF S.A. (0001122491) (Filer)
These mid-cap stocks were the best performers in the last week. Are they in your portfolio? Bilibili Inc. (NASDAQ:BILI) shares rose 23.32% following last week’s release of ‘San Guo: Mou Ding Tian Xia.’ Also, JP Morgan analyst Daniel Chen upgraded Bilibili from Neutral to Overweight and announced a $21 price forecast. ImmunityBio, Inc. (NASDAQ:IBRX) shares jumped 22.36% on continued strength after the announcement of insurance coverage of ANKTIVA across multiple states with the first commercial doses administered. Sasol Ltd. (NYSE:SSL) shares escalated 20.89% after the company announced that the court ruled in favor of the company and TotalEnergies SE (NYSE:TTE) Marketing. Also, it
Barclays analyst Benjamin Theurer maintains BRF (NYSE:BRFS) with a Overweight and raises the price target from $4 to $4.5.
U.S. stocks were higher, with the Dow Jones index gaining over 100 points on Monday. Shares of M&T Bank Corporation (NYSE:MTB) rose sharply during Monday’s session after the company reported first-quarter financial results. Revenue of $2.260 billion, slightly missing the consensus of $2.263 billion. EPS was $3.09, which came in line with the consensus, according to data from Benzinga Pro. M&T Bank shares surged 5.4% to $141.88 on Monday. Here are some other big stocks recording losses in today’s session. Snap One Holdings Corp. (NASDAQ:SNPO) shares jumped 31.6% to $10.71 after the company announced that it will be acquired by Resideo Technologies. Medical Properties Trust, Inc. (NYS